GlassScriptPhysician profile
Ayushi Chauhan
NPI 1134506942
$5,218.95
in general payments reported to CMS, 2019-2025
13 companies · $396 in 2025
The $396 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $171 · 2023: $4,604 · 2024: $48.22 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,000 · Food and Beverage: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,000.00 |
| Food and Beverage | $1,048.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $4,000.00 | 2023 | |
| Secura Bio, INC. | $391.95 | 2022-2025 | Copiktra |
| Janssen Scientific Affairs, LLC | $173.15 | 2023 | Imbruvica |
| Adc Therapeutics America, INC. | $164.69 | 2025 | |
| Beigene USA, INC. | $153.39 | 2023 | Brukinsa |
| Incyte Corporation | $125.00 | 2023 | Monjuvi |
| Genentech USA, INC. | $74.16 | 2025 | |
| Insulet Corporation | $47.71 | 2025 | Omnipod |
| Abbvie INC. | $34.77 | 2024 | |
| Dexcom, INC. | $20.79 | 2025 | Dexcom G6 Transmitter |
| Alexion Pharmaceuticals, INC. | $19.89 | 2025 | Strensiq |
| Btg International INC. | $13.45 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayushi Chauhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.